2017-11-03T12:38:38-05:00 2016-12-31 ERNST & YOUNG US LLP 111 MONUMENT CIRCLE STE 4000 INDIANAPOLIS IN 46204 990 2016-01-01 131924236 Memorial Sloan-Kettering Cancer Center % MARK K SVENNINGSON MEMO 6462273092 1275 YORK AVENUE NEW YORK NY 100656007 MARK K SVENNINGSON SVP & CONTROLLER 6462273092 2017-11-03 JENNIFER RHODERICK P00395735 3176817000 76.184.247.124 35057220173075000005 2017-11-03 P 582F47EFACDD6166E52205D1FBFEA2601660FA18 C0D8C5AAA40E33188D67D924048345967BDA0662 2016 2021-01-29 14:40:06Z CRAIG THOMPSON MD 1275 YORK AVENUE NEW YORK NY 100656007 669351428 false X WWW.MSKCC.ORG X 1960 NY LEADERSHIP IN THE PREVENTION, TREATMENT, AND CURE OF CANCER THROUGH EXCELLENCE, VISION, AND COST EFFECTIVENESS IN PATIENT CARE, OUTREACH PROGRAMS, RESEARCH, AND EDUCATION 31 29 18239 943 1958698 0 51108585 67090737 519256000 519297000 201680279 21993410 14657850 22535819 786702714 630916966 900000 1100000 0 0 359258456 347235942 215653 139618 63193061 339494341 359551297 699868450 708026857 86834264 -77109891 5250565000 5347686000 3150136000 3292648000 2100429000 2055038000 X MEMORIAL SLOAN-KETTERING CANCER CENTER IS DEDICATED TO THIS MISSION: LEADERSHIP IN THE PREVENTION, TREATMENT, AND CURE OF CANCER THROUGH EXCELLENCE, VISION, AND COST-EFFECTIVENESS IN PATIENT CARE, OUTREACH PROGRAMS, RESEARCH, AND EDUCATION. false true 566440663 0 514097000 MEMORIAL SLOAN-KETTERING CANCER CENTER PROVIDES THE FOLLOWING SERVICES TO ITS AFFILIATED ORGANIZATIONS: FINANCIAL ADMINISTRATION, EXECUTIVE MANAGEMENT, HUMAN RESOURCES, FACILITY MANAGEMENT, GENERAL AND ENVIRONMENTAL SERVICES, PROCUREMENT, PUBLIC AFFAIRS, RESEARCH TECHNOLOGY MANAGEMENT, CORPORATE COMPLIANCE, INFORMATION SYSTEMS AND TECHNOLOGY, AND INVESTMENT MANAGEMENT. IN ADDITION, CERTAIN SERVICES ARE PROVIDED ON A REQUISITION BASIS INCLUDING FOOD AND DIETARY SERVICES, FACILITIES MANAGEMENT (LOCKSMITH, ELECTRICIAN, PLUMBING, PAINTING AND CARPENTRY, ETC.) MEDICAL LIBRARY, CONFERENCE PLANNING, OCCUPANCY OF LEASED SPACE, TRANSPORTATION, IMMIGRATION SERVICES, MEDICAL ILLUSTRATION, MOTION MEDIA, SECURITY SERVICES SUCH AS INSTALLING ANTITHEFT DEVICES AND MAILROOM SERVICES. 15186440 0 0 MSKCC PAYS FEES TO CORNELL MEDICAL CENTER AND OTHER MEDICAL INSTITUTIONS FOR STAFF TO FURTHER THEIR SCIENTIFIC EDUCATION. IN ADDITION, THE CENTER HOSTS A NUMBER OF SYMPOSIUMS, SOME OF WHICH ARE OPEN TO THE PUBLIC. 14750035 1100000 9419000 CAFETERIA: THE CENTER OPERATES A CAFETERIA IN THE MAIN BUILDING COMPLEX WHERE VISITORS AND PATIENTS CAN PURCHASE MEALS AND SNACKS. SOCIETY OF MSKCC: THE SOCIETY OF MEMORIAL SLOAN-KETTERING CANCER CENTER, FOUNDED IN 1946, IS A VOLUNTEER ORGANIZATION DEDICATED TO PROMOTING THE WELL-BEING OF PATIENTS, SUPPORTING CANCER RESEARCH AND PROVIDING PUBLIC EDUCATION ON THE PREVENTION, EARLY DETECTION AND TREATMENT OF CANCER. THE COSTS SHOWN HERE ARE EXCLUSIVE OF FUNDRAISING ACTIVITIES, WHICH ARE REPORTED IN PART IX, COLUMN D. CAFETERIA EXPENSE $8,569,786 REVENUE $5,200,000 SOCIETY EXPENSE $2,074,249 GRANTS TO RALPH LAUREN CENTER -SEE SCHEDULE I GRANT EXP $1,100,000 PROSTATE CANCER CLINICAL TRIALS CONSORTIUM EXPENSES $3,006,000 REVENUE 4,219,000 596377138 true true false true false false false false false true true true false false true false false true false false true false false true true false false true false true true false false false false false false false false false true true false false false true true true true false false true 1568 0 true 18239 true true true true LU false false false true true false false false false X 31 29 false false false false false false false true true false false false true true true true true true true true true AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA PR RI SC SD TN TX UT VT VA WA WV WI WY X X MARK K SVENNINGSON 6462273414 633 THIRD AVENUE New York NY 10017 X RICHARD I BEATTIE BOARD MEMBER 1.0 0.0 X 0 0 0 STANLEY F DRUCKENMILLER BOARD MEMBER 1.0 0.0 X 0 0 0 RICHARD N FOSTER BOARD MEMBER 1.0 0.0 X 0 0 0 STEPHEN FRIEDMAN BOARD MEMBER 1.0 0.0 X 0 0 0 ELLEN V FUTTER BOARD MEMBER 1.0 0.0 X 0 0 0 LOUIS V GERSTNER JR BOARD MEMBER 1.0 0.0 X 0 0 0 JONATHAN N GRAYER BOARD MEMBER 1.0 0.0 X 0 0 0 BENJAMIN W HEINEMAN JR BOARD MEMBER 1.0 0.0 X 0 0 0 DAVID H KOCH BOARD MEMBER 1.0 0.0 X 0 0 0 MARIE-JOSEE KRAVIS BOARD MEMBER 1.0 0.0 X 0 0 0 DEBORAH C WRIGHT BOARD MEMBER 1.0 0.0 X 0 0 0 CRAIG THOMPSON MD BOARD MBR, PRESIDENT & CEO 50.0 0.0 X X 5337371 0 1381832 JAMES G NIVEN BOARD MEMBER 1.0 0.0 X 0 0 0 BRUCE C RATNER BOARD MEMBER 1.0 0.0 X 0 0 0 CLIFTON S ROBBINS BOARD MEMBER & TREASURER 2.0 0.0 X X 0 0 0 JAMES D ROBINSON III BD MEMBER & HONORARY CHAIRMAN 2.0 0.0 X 0 0 0 NORMAN C SELBY BOARD MEMBER & SECRETARY 2.0 0.0 X X 0 0 0 STEPHEN C SHERRILL BOARD MEMBER 1.0 0.0 X 0 0 0 SCOTT M STUART VICE CHAIRMAN OF THE BOARD 2.0 0.0 X X 0 0 0 DOUGLAS A WARNER III CHAIRMAN OF THE BOARD 2.0 0.0 X X 0 0 0 ANTHONY B EVNIN BOARD MEMBER 1.0 0.0 X 0 0 0 VIRGINIA M ROMETTY BOARD MEMBER 1.0 0.0 X 0 0 0 PETER J SOLOMON BOARD MEMBER 1.0 0.0 X 0 0 0 PETER A WEINBERG BOARD MEMBER 1.0 0.0 X 0 0 0 WILLIAM E FORD BOARD MEMBER 1.0 0.0 X 0 0 0 JAMIE C NICHOLLS BOARD MEMBER 1.0 0.0 X 0 0 0 IAN COOK BOARD MEMBER 1.0 0.0 X 0 0 0 ALEXANDER T ROBERTSON BOARD MEMBER 1.0 0.0 X 0 0 0 LAVINIA BRANCA SNYDER BOARD MEMBER 1.0 0.0 X 0 0 0 JOHN R STRANGFELD BOARD MEMBER 1.0 0.0 X 0 0 0 ROGER W FERGUSON BOARD MEMBER 1.0 0.0 X 0 0 0 ERIC M COTTINGTON SVP, RESEARCH & TECH MGMT 50.0 0.0 X 885023 0 76996 MICHAEL P GUTNICK EVP & CFO 50.0 0.0 X 1648988 0 72706 JASON KLEIN SVP & CHIEF INVESTMENT OFFICER 50.0 0.0 X 2811422 0 1592843 EDWARD MAHONEY SVP, FACILITIES MGMT & CONST 50.0 0.0 X 1561293 0 68033 RICHARD K NAUM SVP, DEVELOPMENT 50.0 0.0 X 683152 0 77535 PATRICIA C SKARULIS SVP & CHIEF INFO OFFICER 50.0 0.0 X 958884 0 54805 KERRY BESSEY SVP & CHIEF HR OFFICER 50.0 0.0 X 896440 0 68804 CAROLYN LEVINE ESQ DEPUTY GEN COUNSEL CORP SECTY 50.0 0.0 X 486571 0 38518 EDWIN TALIAFERRO VP INTERNAL AUDIT & COMPLIANCE 50.0 0.0 X 512126 0 50236 AVICE MEEHAN SVP CH COMMUNICATION OFFICER 50.0 0.0 X 605954 0 54906 KATHRYN MARTIN COO 50.0 0.0 X 1738256 0 81313 JORGE LOPEZ EVP & GENERAL COUNCEL 50.0 0.0 X 545347 0 47236 ANNE E MCSWEENEY SPECIAL ADVISOR TO PRESIDENT 50.0 0.0 X 1307735 0 72180 MARK SVENNINGSON SVP FINANCE, CONTROLLER 50.0 0.0 X 879585 0 81370 WILLIAM DIXON DIRECTOR PUBLIC INVESTMENTS 50.0 0.0 X 655869 0 59532 STEPHEN RASKIN VP, TECHNOLOGY DEVELOPMENT 50.0 0.0 X 654223 0 62302 JAMES T HARDEN SVP, STRATEGIC PARTNERSHIPS 50.0 0.0 X 681261 0 65967 TOMYA RYANS VP TALENT ACQUISITION 50.0 0.0 X 661450 0 54263 WILLIAM MORGAN VP HR SYSTEMS & OPERATIONS 50.0 0.0 X 660247 0 59115 JOHN R GUNN 2015 RETIRED FORMER COO 0.0 0.0 X 229167 0 0 ROGER PARKER EVP & GENERAL COUNCEL-7/2016 0.0 0.0 X 642932 0 29555 25043296 0 4150047 943 true true false TURNER CONSTRUCTION 375 HUDSON STREET NEW YORK NY 10014 GENERAL CONSTRUCT 227973293 JGN CONSTRUCTION CORP 66-40 69TH STREET MIDDLE VILLAGE NY 11379 GENERAL CONSTRUCT 24228039 PERKINS EASTMAN ARCHITECTS 115 FIFTH AVENUE NEW YORK NY 10003 ARCHITECTURAL 9568831 HUNTER ROBERTS CONSTRUCTION GR LLC 2 WORLD FINANCIAL CENTER NEW YORK NY 10001 GENERAL CONSTRUCT 70764535 WM BLANCHARD 199 MOUNTAIN AVENUE SPRINGFIELD NJ 07081 GENERAL CONSTRUCTION 7773701 178 1074953 187000 65828784 2241636 67090737 SERVICES PROVIDED SEE NOTE A & ATTACH.1 IN SCH O 900099 514097000 514097000 CAFETERIA 721000 5200000 5200000 519297000 11144410 1958698 9185712 8564000 8564000 6724000 6724000 0 0 0 39846523 37561523 2285000 2285000 2285000 2559418 1074953 872939 1686479 1686479 0 0 0 0 0 0 RESEARCH EXPENSE RECOVERY 711110 4219000 4219000 GIFT SHOP INCOME 811000 1626000 1626000 VENDOR DISCOUNT 900099 1451000 1451000 6829340 6829340 14125340 630916966 523516000 1958698 38351531 1100000 1100000 0 0 0 24581238 16685897 5754739 2140602 901654 672487 229167 262849669 236558109 5472303 20819257 24081037 22239092 400876 1441069 17366303 12176412 1464610 3725281 17456041 15693321 378558 1384162 0 5646740 4983345 468319 195076 716333 697283 18456 594 896016 896016 139618 139618 7886480 7886480 39183379 34069896 1915306 3198177 17629436 16396137 1483 1231816 118629438 86949519 8144895 23535024 23615876 23303087 52798 259991 5823820 5823820 29412460 27471116 786804 1154540 2331536 1482561 256985 591990 0 4094536 2865609 456780 772147 28853602 23077636 5775966 0 50374097 48820909 655242 897946 1607021 1471083 23163 112775 ALLOCATION OF INDIRECT COSTS 23137689 18255569 2416185 2465935 FUNDRAISING EVENTS -872939 -872939 UBIT EXPENSE 73723 73723 ALL OTHER 512054 512054 708026857 596377138 48456658 63193061 X 16344917 8282854 8062063 211495000 341360000 250782000 313879000 117729000 129647000 709894000 726421000 0 0 0 0 30538000 32704000 527000 406000 496460000 88870000 891258000 478070000 258293000 413188000 2566951000 2688829000 587863000 592226000 20033000 20156000 0 0 0 0 5250565000 5347686000 314714000 380426000 0 0 0 0 1701075000 1265956000 0 0 0 0 0 0 823060000 1350000000 311287000 296266000 3150136000 3292648000 X 1722110000 1688756000 206157000 189407000 172162000 176875000 2100429000 2055038000 5250565000 5347686000 X -77109891 63416386 -31697495 X X false true X true true true X 50714750 18153930 67704247 51108585 67090737 254772249 0 0 50714750 18153930 67704247 51108585 67090737 254772249 0 254772249 36776921 35655783 21521254 63076697 26432410 183463065 0 0 438235314 2570644012 0.58136 0.53660 X PART I, LINE 3 THE INTERNAL REVENUE SERVICE HAS DETERMINED THAT MEMORIAL SLOAN-KETTERING CANCER CENTER QUALIFIES AS A PUBLIC CHARITY UNDER SECTION 170 (B) (1) (A) (iii). HOWEVER, SINCE IT DOES NOT OPERATE A HOSPITAL, IT IS NOT REQUIRED TO COMPLETE SCHEDULE H. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED X 896016 896016 896016 896016 707130041 3780351183 708026057 3781247199 1000000 1000000 250000 250000 1000000 1000000 1000000 1000000 4000000 6000000 526688 414936 733578 896016 2571218 250000 250000 250000 250000 1000000 1500000 PART II-A ALL LOBBYING ACTIVITIES ARE PERFORMED BY MEMORIAL SLOAN-KETTERING CANCER CENTER (EIN 13-1924236). LOBBYING EXPENDITURES ARE EXPENSED BY THE CENTER AND ARE REPORTED ON THE STATEMENT OF FUNCTIONAL EXPENSE LINE 11d. THE CENTER HAS MADE THE 501(h) ELECTION. OUR AFFILIATED ORGANIZATIONS ARE IDENTIFIED BELOW. ALL AFFILIATES USE THE CORPORATE ADDRESS 1275 YORK AVENUE, NEW YORK, N.Y. 10065-6007. MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES (13-1624082), SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (13-1624182), SKI REALTY, INC. (13-3389586), LOUIS V. GERSTNER JR., GRADUATE SCHOOL (20-2212588), MSK. INSURANCE U.S., INC. (83-0363317), AND MSKCC PROTON INC., (35-2397819) 211696215 13020 5436122 217145357 213471000 19530 -1794315 211696215 205654000 69000 7748000 213471000 197211000 105000 12885000 4547000 205654000 188092000 123000 8996000 197211000 0.18550 0.81450 false false 370727000 68221000 302506000 17712000 14569000 3143000 502819000 395280000 107539000 413188000 NON MARKETABLE SECURITIES 26058000 C PRIVATE EQUITY & VENTURE CAP 566168000 F 592226000 0 PENSION AND POSTRETIREMENT 104174000 DEFERRED GIFT ANNUITY 22459000 ASSET RETIREMENT OBLIGATION 3272000 INSURANCE RESERVES 4167000 CAPTIVE INSURANCE LOAN AGREEME 161799000 ACCRUED SICK PAY 395000 296266000 675306495 63416386 872939 64289325 611017170 19899796 19899796 630916966 687900000 872939 872939 687027061 19899796 1100000 20999796 708026857 INTENDED USE OF ENDOWMENT FUNDS PERMANENT ENDOWMENT FUNDS ARE HELD BY THE ORGANIZATION IN PERPETUITY. INCOME EARNED ON THE FUND BALANCE IS USED TO SUPPORT THE OPERATIONS OF MEMORIAL SLOAN-KETTERING CANCER CENTER. FIN 48 LIABILITY FOR UNCERTAIN TAX POSITIONS A FIN 48 FOOTNOTE DISCLOSURE, RELATING TO THE ACCOUNTING FOR INCOME TAXES, WAS NOT REQUIRED BECAUSE THERE WAS NO MATERIAL IMPACT ON THE INSTITUTION'S FINANCIAL STATEMENTS. OTHER RECONCILING ITEMS lines 2d DIRECT EXPENSES RELATING TO FUNDRAISING EVENTS. COSTS ARE REMOVED FROM THE FUNCTIONAL EXPENSES AND NETTED ON THE STATEMENT OF REVENUE $872,939. OTHER RECONCILING ITEMS line 4b GRANT PAYMENTS TO RALPH LAUREN CENTER RECORDED BY MSK AS NON OPERATING EXPENSES TOTAL $1,100,000. Europe (Including Iceland and Greenland) Program Services INVESTMENT MEETINGS 87251 East Asia and the Pacific Program Services INVESTMENT MEETINGS 41827 North America Program Services INVESTMENT MEETINGS 10173 Central America and the Caribbean Investments 1298810165 Europe (Including Iceland and Greenland) Investments 82999876 Sub-Saharan Africa Investments 1687865 1383637157 1383637157 true false true true true false Organization's Procedures for Monitoring Use of Grant Funds Outside the US MEMORIAL SLOAN-KETTERING CANCER CENTER DOES NOT MAKE GRANTS OR USE GRANT MONEY OUTSIDE THE UNITED STATES. SCHEDULE F, PART I , LINE 3, COLUMN f VALUES SHOWN IN COLUMN F ARE THE MARKET VALUES FOR THE INVESTMENTS AT DECEMBER 31. X X X X X X X true DONOR SERVICES 6715 SUNSET BLVD HOLLYWOOD CA 90028 TELEMARKET false 686072 139618 546454 686072 139618 546454 All States SPRING BALL 1348285 237324 1110961 104246 27600 89730 FALL PARTY 521844 257844 264000 72010 5000 55752 5 1764242 579785 1184457 94932 219820 13575 190274 3634371 1074953 2559418 94932 396076 46175 335756 872939 1686479 true RALPH LAUREN CTR FOR CANCER & PREVENTION 1919 MADISON AVENUE NEW YORK NY 10035 020597827 501(C)(3) 1100000 OPERATING LOSSES 1 Form 990, Schedule I RALPH LAUREN CENTER FOR CANCER CARE & PREVENTION. DURING 2016, MSKCC PAID $1,100,000 TO THE RALPH LAUREN CENTER FOR CANCER CARE & PREVENTION TO OFFSET OPERATING EXPENSES. THE AMOUNT PAID IN THE CURRENT YEAR INCLUDES $100,000 FOR 2015 LOSSES. THE BOARD HAD APPROVED RESOLUTIONS TO SUPPORT THE RALPH LAUREN CENTER'S LOSSES UP TO $1,000,000 PER YEAR FROM 2014-2016. MSKCC REGULARLY MEETS WITH THE RALPH LAUREN CENTER'S BOARD OF DIRECTORS TO REVIEW THAT THEIR SPENDING IS IN CONFORMITY WITH THEIR MISSION. X X true true X X X X X false true false false false false false true true true ANNE E MCSWEENEY SPECIAL ADVISOR TO PRESIDENT 967518 279362 60855 30450 41730 1379915 9250 MARK SVENNINGSON SVP FINANCE, CONTROLLER 600143 245786 33656 39700 41670 960955 18500 ERIC M COTTINGTON SVP, RESEARCH & TECH MGMT 538639 289266 57118 39700 37296 962019 18500 JOHN R GUNN 2015 RETIRED FORMER COO 229167 229167 MICHAEL P GUTNICK EVP & CFO 911697 689772 47519 39700 33006 1721694 18500 JASON KLEIN SVP & CHIEF INVESTMENT OFFICER 834561 1949306 27555 1552528 40315 4404265 18500 EDWARD MAHONEY SVP, FACILITIES MGMT & CONST 516489 1011733 33071 39700 28333 1629326 17624 RICHARD K NAUM SVP, DEVELOPMENT 425903 218495 38754 38399 39136 760687 17198 PATRICIA C SKARULIS SVP & CHIEF INFO OFFICER 625211 315173 18500 39700 15105 1013689 18500 CRAIG THOMPSON MD BOARD MBR, PRESIDENT & CEO 1558276 3740063 39032 1213562 168270 6719203 18500 WILLIAM DIXON DIRECTOR PUBLIC INVESTMENTS 388784 259823 7262 27774 31758 715401 6281 KERRY BESSEY SVP & CHIEF HR OFFICER 550375 279377 66688 39700 29104 965244 18500 CAROLYN LEVINE ESQ DEPUTY GEN COUNSEL CORP SECTY 367785 111395 7391 25849 12669 525089 4775 EDWIN TALIAFERRO VP INTERNAL AUDIT & COMPLIANCE 306469 159150 46507 26530 23706 562362 5330 AVICE MEEHAN SVP CH COMMUNICATION OFFICER 393441 201250 11263 25698 29208 660860 6875 KATHRYN MARTIN COO 1000437 707700 30119 39700 41613 1819569 18500 STEPHEN RASKIN VP, TECHNOLOGY DEVELOPMENT 426645 218875 8703 28944 33358 716525 7974 JAMES T HARDEN SVP, STRATEGIC PARTNERSHIPS 476805 195206 9250 30450 35517 747228 9250 ROGER PARKER EVP & GENERAL COUNCEL-7/2016 292325 325780 24827 24056 5499 672487 18500 JORGE LOPEZ EVP & GENERAL COUNCEL 518293 27054 27537 19699 592583 TOMYA RYANS VP TALENT ACQUISITION 315597 281953 63900 24340 29923 715713 2586 WILLIAM MORGAN VP HR SYSTEMS & OPERATIONS 470024 131758 58465 24420 34695 719362 2586 SUPPLEMENTAL COMPENSATION INFORMATION BUSINESS OR FIRST CLASS TRAVEL IS ALLOWED FOR FLIGHTS GREATER THAN 6 CONTINUOUS HOURS FOR ANY EMPLOYEE NOT FUNDED BY FEDERAL GRANTS. EXCEPTIONS TO THE SIX HOUR RULE ARE REVIEWED ON AN INDIVIDUAL BASIS. ALL TRAVEL MUST BE APPROVED BEFORE ANY ARRANGEMENTS ARE MADE. MSKCC HAS AN ACCOUNTABLE TRAVEL POLICY AND THEREFORE, DOES NOT INCLUDE TRAVEL AS TAXABLE COMPENSATION. THE DUTIES TO BE PERFORMED BY OUR PRESIDENT REQUIRE HIM TO BE ON CALL AND TO PERFORM DUTIES AS AND WHEN APPROPRIATE DURING HIS NORMAL OFF-DUTY PERIODS AS WELL AS DURING NORMAL OFFICE HOURS. AN EMPLOYMENT CONTRACT REQUIRES OUR PRESIDENT TO LIVE IN THE OFFICIAL RESIDENCE OWNED AND MAINTAINED BY MSK. THE CONTRACT REQUIRES OUR PRESIDENT TO USE THE RESIDENCE FOR BUSINESS PURPOSES, INCLUDING, BUT NOT LIMITED TO, MEETINGS WITH AND ENTERTAINMENT OF STAFF, DONORS AND POTENTIAL DONORS, VISITING PROFESSORS AND SCIENTISTS, AND OTHER PERSONS INVOLVED WITH THE AFFAIRS OF THE ORGANIZATION, CONFIDENTIAL INTERVIEWS WITH MEMBERS AND PROSPECTIVE MEMBERS OF THE STAFF; AND FOR OTHER BUSINESS ACTIVITIES CONDUCTED DURING AND OUTSIDE OF NORMAL OFFICE HOURS. THE COST IS REPORTED AS COMPENSATION ON FORM 990 AND IS EXCLUDED FROM TAXABLE COMPENSATION IN ACCORDANCE WITH CODE SECTION 119. SCHEDULE J PART I LINE 4B THE CENTER MAINTAINS A NONQUALIFIED DEFERRED COMPENSATION PLAN WHICH IS USED FOR EMPLOYER CONTRIBUTIONS IN EXCESS OF THOSE ALLOWED BY THE RETIREMENT ANNUITY PLAN. NO PAYMENTS WERE MADE DURING THE CURRENT YEAR. SCHEDULE J, PART I, LINE 7 INCENTIVE PAY IS PROVIDED TO OFFICERS AND KEY EMPLOYEES BASED ON THEIR ACHIEVEMENT OF GOALS RELATING TO QUALTY OF CARE, PATIENT SAFTEY, OPERATIONAL EFFICIENCY AND FUNCTIONAL PERFORMANCE. SCHEDULE J, PART I, LINE 8 AN EMPLOYMENT CONTRACT WAS ENTERED INTO AND SIGNED PRIOR TO EMPLOYMENT. A DORMITORY AUTHORITY OF THE STATE OF NEW YORK 146000293 649903B91 2008-05-13 456109226 SEE PART VI false false false B DORMITORY AUTHORITY OF THE STATE OF NEW YORK 146000293 649906RK2 2012-02-16 388814944 SEE PART VI false false false C DORMITORY AUTHORITY OF THE STATE OF NEW YORK 146000293 6499063Z7 2013-06-28 80000000 SEE PART VI false false false D DORMITORY AUTHORITY OF THE STATE OF NEW YORK 146000293 000000000 2015-07-16 100000000 SEE PART VI false false false A 75135000 0 456110736 0 0 0 2928705 0 0 0 453182031 0 2008 true false true true B 5280000 0 389043483 0 9172031 0 2651698 0 0 92720595 284499159 0 2014 false true true true C 26000000 0 80000000 0 0 0 0 0 0 0 80000000 0 2013 true false true true D 5308784 0 100300239 0 0 0 0 0 0 0 100300239 0 2015 false true true true A 0 B false false false true false 0 false false false true C false false false true false 0 false false false true D false false false true false 0 false false false true A false false false true false false 0 false 0 false true B false true false false false false 0 false 0 false true C false true false false false false 0 false 0 false true D false true false false false false 0 false 0 false true A true B true C true D true PART 1, COLUMN (F) DESCRIPTION OF PURPOSE 2008-I & II CUSIP #649903ZR5 & #649903B91: 2008-I SERIES BONDS CUSIP #649903ZR5 WITH ISSUE PRICE $164,779,275 AND 2008-II SERIES BONDS CUSIP #649903B91 WITH ISSUE PRICE $291,329,951 ARE COMBINED FOR REPORTING PURPOSE UNDER CUSIP #649903B91. BOTH ISSUES WERE USED TO CURRENT REFUND A PORTION OF THE 2002A BONDS ISSUED JANUARY 24, 2002. 2012 & 2012-I SERIES CUSIP #649906RK2: 2012 SERIES BONDS WERE USED TO CONSTRUCT AND EQUIP AN AMBULATORY FACILITY AND TO ADVANCE REFUND A PORTION OF THE 2003 BONDS ISSUED MAY 14, 2003. 2013 SERIES CUSIP #6499063Z7: 2013 SERIES BONDS WERE USED TO CURRENT REFUND THE 2010 BONDS ISSUED SEPTEMBER 2, 2010. 2015-1 SERIES CUSIP #000000000: 2015 SERIES BONDS WERE USED TO ADVANCE REFUND THE 2006-I BONDS ISSUED JUNE 29, 2006. 2016 SERIES (DASNY) CUSIP #000000000 2016 DASNY SERIES BOND WERE USED TO CONSTRUCT/RENOVATE AND UPGRADE AND EQUIP VARIOUS FACILITIES. 2016 SERIES (NJEDA) CUSIP #000000000 2016 NJEDA SERIES BONDS WERE USED TO CONSTRUCT AND EQUIP VARIOUS FACILITIES. PART II LINE 3 THE AMOUNT OF PROCEEDS ON PART II LINE 3 IS DIFFERENT FROM PART I COLUMN (E) BECAUSE PART II LINE 3 INCLUDES INVESTMENT INCOME AND GAINS/LOSSES. PART III LINE 3(D) ANY MANAGEMENT CONTRACTS AND RESEARCH AGREEMENTS THAT MAY RESULT IN PRIVATE BUSINESS USE OF BOND FINANCED PROPERTIES ARE REVIEWED FIRST BY IN-HOUSE STAFF WHO ARE KNOWLEDGEABLE OF AND RESPONSIBLE FOR THE FORM 990. OUTSIDE COUNSEL IS CONSULTED IF QUESTIONS ARISE. PART IV LINE 2 THE 2008 SERIES BONDS REBATE CALCULATIONS WERE LAST PERFORMED ON MAY 12, 2013. A DORMITORY AUTHORITY OF THE STATE OF NEW YORK 146000293 000000000 2016-04-28 110000000 SEE PART VI false false false B NEW JERSEY ECONOMIC DEVELOPMENT AUTHORITY 222045817 000000000 2016-09-09 145000000 SEE PART VI false false false A 572866 0 110247909 0 0 0 155282 0 0 110017627 75000 0 2016 false false false true B 0 0 145000000 0 0 0 72861 0 0 144627139 300000 0 false false false true A false false false true false 0 false false false true B false false false true false 0 false false false true A false true false false false false 0 false 0 false true B false true false false false false 0 false 0 false true A true B true KING STREET CAPITAL MANAGEMENT SEE PART V 684233 INVESTMENT MANAGEMENT FEES false BUSINESS TRANSACTIONS INVOLVING INTERESTED PERSONS MS. JAMIE NICHOLLS IS A BOARD MEMBER OF THE CENTER. HER SPOUSE IS A CO-FOUNDER OF KING STREET CAPITAL MANAGEMENT. DURING 2016, THE CENTER PAID KING STREET $684,233 IN MANAGEMENT FEES. THE INVESTMENT AGREEMENT CALLS FOR CARRIED INTEREST THAT IS NORMAL AND CUSTOMARY IN THE COURSE OF INVESTING IN ALTERNATIVE INVESTMENTS. MS. NICHOLLS WAS NOT A PARTY TO THE TRANSACTIONS. THERE IS NO SHARING OF THE CENTER'S REVENUE. THE PURCHASES OF GOODS AND SERVICES BY THE CENTER WERE MADE IN THE ORDINARY COURSE OF BUSINESS, AT COMMERCIALLY AVAILABLE RATES normally charged to regular customers. X 926390 THRIFT VALUE X 104 2168104 MARKET VALUE false true false SALE OF NON CASH CONTRIBUTIONS EXCLUDED FROM THIS VALUE ARE PLEDGE PAYMENTS, MADE BY STOCK, TOTALING $73,532. PROMISES TO GIVE ARE REPORTED AT THE DATE THE INTENT IS MADE IN WRITING. CLOTHING AND HOUSEHOLD GOODS ARE DONATED TO OUR THRIFT SHOP. THE SOCIETY OF MSKCC RUNS THE THRIFT SHOP FOR THE BENEFIT OF THE ORGANIZATION. PUBLICLY TRADED DONATED STOCK IS SOLD BY MERRILL LYNCH ON BEHALF OF MEMORIAL SLOAN-KETTERING CANCER CENTER. NOTE A - AFFILIATED ORGANIZATIONS MEMORIAL SLOAN-KETTERING CANCER CENTER (THE CENTER) IS AFFILIATED WITH THE FOLLOWING 501 (C) (3) ORGANIZATIONS: SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (THE INSTITUTE), MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES (THE HOSPITAL), S.K.I. REALTY, INC., MSK INSURANCE US, INC., THE LOUIS V. GERSTNER JR., GRADUATE SCHOOL OF BIOMEDICAL SCIENCES, MSKCC PROPERTIES LLC, WITH MEMORIAL HOSPITAL BEING THE SOLE MEMBER, THE PROSTATE CANCER CLINICAL TRIALS CONSORTIUM WITH THE CENTER BEING THE SOLE MEMBER AND MSKCC PROTON INC. THE ORGANIZATIONS SHARE CERTAIN FACILITIES AND VARIOUS SERVICES INCLUDING ADMINISTRATIVE, PLANT AND ANCILLARY SERVICES. THE FOLLOWING IS A SUMMARY OF SUCH SERVICES: SERVICES PROVIDED TO THE CENTER BY: THE HOSPITAL $ 8,731,000 THE INSTITUTION $ 7,487,000 S.K.I. REALTY,INC. $ 2,319,000 TOTAL $ 18,537,000 SERVICES PROVIDED BY THE CENTER TO: THE HOSPITAL $416,343,000 THE INSTITUTION $ 93,893,000 S.K.I. REALTY,INC. $ 3,420,000 GERSTNER GRADUATE SCHOOL $101,000 PROSTATE CANCER CLINICAL TRIALS CONSORTIUM $ 340,000 TOTAL $514,097,000 MEMORIAL SLOAN-KETTERING CANCER CENTER, AND ITS AFFILIATES, ARE COLLECTIVELY REFERRED TO AS "THE ORGANIZATION". THE CENTER CARRIES ON FUNDRAISING ACTIVITIES ON ITS OWN BEHALF AND ON BEHALF OF THE AFFILIATES. CONTRIBUTIONS AND PLEDGES ARE RECORDED BASED ON THE DONOR'S INTENT IN THE RECORDS OF THE APPROPRIATE ENTITY. FOR 2016, TOTAL CONTRIBUTIONS AND PLEDGES RAISED ON BEHALF OF THE CENTER, HOSPITAL, INSTITUTE AND GRADUATE SCHOOL WERE $317,300,000. CONTRIBUTORS' INFORMATION PROVIDED IN THE ATTACHED SCHEDULE B REPRESENTS THE DONORS' TOTAL PHILANTHROPIC CONTRIBUTIONS TO THE CENTER ONLY. IF ANY DONOR LISTED ON SCHEDULE B MADE CONTRIBUTIONS TO THE HOSPITAL, INSTITUTE, OR GRADUATE SCHOOL, THOSE CONTRIBUTIONS WOULD NOT BE REFLECTED ON THE ATTACHED SCHEDULE B. FUNDRAISING EXPENSES OF $63,193,061 WERE INCURRED AND REPORTED BY THE CENTER IN PART IX, STATEMENT OF FUNCTIONAL EXPENSES. THE CENTER IS ALSO INVOLVED IN LOBBYING FOR THE HOSPITAL AND INSTITUTE. SEE SCHEDULE C. PART III, LINE 3 STAFF HOUSING AND PARKING SERVICES ARE NOW BEING PROVIDED BY OUR AFFILIATE S.K.I. REALTY, INC. THE RELATED PROGRAM EXPENSES AND REVENUE ARE REPORTED ON FORM 990 FOR EXEMPT GROUP 3475, MEMORAL SLOAN-KETTERING CANCER CENTER EIN 91-2154267. FORM 990, PART VI, LINE 11B PRIOR TO FILING THE RETURN, A REVIEW OF THE 990 WAS CONDUCTED BY THE CONTROLLER AND THE CHIEF FINANCIAL OFFICER. IN ADDITION, FORM 990 IS PREPARED IN CONJUNCTION WITH ERNST AND YOUNG, LLP. FORM 990, PART VI, LINE 12C THE COMPLIANCE OFFICER AND STAFF ARE RESPONSIBLE FOR ADMINISTERING THE CONFLICT OF INTEREST PROGRAM--INCLUDING THE IMPLEMENTATION OF THE POLICY--BY MAINTAINING PROCESSES FOR DISCLOSURE OF OUTSIDE ACTIVITIES AND FOR THE TIMELY REVIEW OF REPORTED INTERESTS, INCLUDING: 1. MANAGEMENT OF THE ANNUAL DISCLOSURE CERTIFICATION PROCESS AND THE PROCESS BY WHICH COVERED PERSONS DISCLOSE AT TIME OF HIRE. COVERED PERSONS RECEIVE AN ANNUAL QUESTIONNAIRE REQUESTING DISCLOSURE OF RELATIONSHIPS AND TRANSACTIONS THAT MIGHT INVOLVE A CONFLICT OF INTEREST. QUESTIONNAIRE RESPONSES ARE REVIEWED BY THE COMPLIANCE OFFICER AND STAFF. FOLLOW-UP INQUIRIES ARE MADE IF NEEDED. MATTERS ARE SUBMITTED TO AN INTERNAL MANAGEMENT COMMITTEE AND A COMMITTEE OF THE BOARD OF MANAGERS IF ADJUDICATION IS NEEDED. 2. REVIEW AND ADJUDICATION OF OUTSIDE ACTIVITIES THAT REQUIRE PREAPPROVAL OR DISCLOSURE; FACILITATION OF A REVIEW BY THE OFFICE OF INDUSTRIAL AFFAIRS OF ANY OUTSIDE ACTIVITIES THAT INVOLVE INTELLECTUAL PROPERTY OR OTHERWISE INVOLVE AN ACTIVITY IN WHICH THE CENTER'S RIGHTS MAY REQUIRE PROTECTION. 3. ADMINISTRATION OF CONFLICT OF INTEREST ADVISORY COMMITTEE MEETINGS (COIAC, INCLUDING DEVELOPMENT AND DISTRIBUTION OF AGENDAS AND SUPPORTING DOCUMENTS, DRAFTING AND DISTRIBUTION OF MINUTES, AND MAINTENANCE OF COMMITTEE RECORDS. 4. DOCUMENTATION OF THE OUTCOMES OF ALL REVIEWS OF REPORTED OUTSIDE ACTIVITIES. COMMUNICATION TO THE COVERED PERSON OF THE OUTCOME OF ALL REVIEWS, INCLUDING DOCUMENTATION OF MANAGEMENT PLANS. AS PART OF THE CLINICAL RESEARCH REVIEW PROCESS, QUESTIONS ON THE PROTOCOL SUBMISSION FORM ARE DESIGNED TO ELICIT INFORMATION ABOUT POTENTIAL CONFLICTS. SITUATIONS IN WHICH A STAFF PARTICIPANT IN RESEARCH REPORTS A POTENTIAL CONFLICT ARE REFERRED TO THE CHAIR OF THE COIAC AND TO THE COMPLIANCE OFFICER FOR REVIEW. 5. THE BOARD OF MEMORIAL SLOAN-KETTERING CANCER CENTER HAS MEMBERS THAT ACTIVELY SERVE AS OFFICERS AND/OR BOARD MEMBERS OF PUBLICLY TRADED COMPANIES. THE ORGANIZATION MAY PROCURE GOODS AND/OR SERVICES FROM THESE PUBLICLY TRADED COMPANIES THROUGH THE ORDINARY COURSE OF THE COMPANIES' BUSINESS ON TERMS AND CONDITIONS WHICH ARE NOT INFLUENCED BY MEMBERS OF OUR BOARD OF MANAGERS AND WHICH WE ASSUME ARE THE SAME THAT SUCH COMPANIES CHARGE TO THE GENERAL PUBLIC. THE ORGANIZATION HAS A COMPREHENSIVE CONFLICT OF INTEREST POLICY. TRANSACTIONS IDENTIFIED THROUGH OUR CONFLICT OF INTEREST QUESTIONNAIRE ARE DISCLOSED ON SCHEDULE L. THESE TRANSACTIONS ARE CONSUMMATED ON AN ARM'S LENGTH BASIS BETWEEN MANAGEMENT OF THE INSTITUTION AND THE COMPANY. ORGANIZATION's "Policy on Conflicts of Interests for Directors and Key Employees" applies to any Board of Managers member, principal officer, or member of a committee with Board-delegated powers. Individuals covered by this policy have a duty to disclose Financial Interests, as defined by the Policy, annually and as they arise. In the event a covered individual is involved in a Board or committee action (such as approval of a transaction or arrangement) and the individual has a Financial Interest related to the matter before the Board, the individual must disclose the Financial Interest and all material facts to the Board or committee. The individual must leave the meeting while the determination of a conflict of interest is discussed and voted upon, and the remaining, disinterested Board or committee members are responsible to decide if a conflict exists. If a determination is made that a conflict exists, the involved individual may make a presentation to the Board or committee but s/he must leave the meeting during the discussion of and the vote on the transaction or arrangement. The Board or committee is required to determine whether the organization can obtain a more advantageous transaction or arrangement with reasonable efforts from an unconflicted person or entity. As appropriate, the chairperson of the Board or Committee is responsible to appoint a disinterested person or committee to investigate alternatives to the proposed transaction or arrangement. FORM 990, PART VI, LINE 15 MEMORIAL SLOAN-KETTERING CANCER CENTER IS COMMITTED TO ENSURING THAT ITS EXECUTIVE COMPENSATION PROGRAM ADHERES TO THE ESTABLISHED STANDARDS OF REGULATORY COMPLIANCE AND BEST CORPORATE GOVERNANCE. THE BOARD OF OVERSEERS AND MANAGERS HAS CHARGED THE JOINT HUMAN RESOURCES COMMITTEE (WHICH IS COMPOSED OF INDEPENDENT BOARD MEMBERS WITH NO CONFLICTS OF INTEREST IN REGARDS TO EXECUTIVE COMPENSATION) WITH MAKING ALL DECISIONS RELATED TO COMPENSATION FOR OFFICERS AND KEY EMPLOYEES. THE COMMITTEE REVIEWS THE TOTAL COMPENSATION OF THE INDIVIDUALS, INCLUDING BOTH CURRENT AND DEFERRED COMPENSATION, AND ALL EMPLOYEE BENEFITS, ON AN ANNUAL BASIS TO ENSURE THAT THE TOTAL COMPENSATION OF EACH OFFICER AND KEY EMPLOYEE IS REASONABLE. TO ASSIST IN THE COMPLETION OF ITS RESPONSIBILITIES, THE COMMITTEE ENGAGES THE SERVICES OF A NATIONALLY RECOGNIZED CONSULTING FIRM SPECIALIZING IN EXECUTIVE COMPENSATION FOR NOT-FOR-PROFIT HEALTHCARE ORGANIZATIONS. EACH YEAR THE COMMITTEE REVIEWS A COMPREHENSIVE REPORT PREPARED BY THE FIRM THAT INCLUDES MARKET DATA FOR FUNCTIONALLY COMPARABLE ROLES IN COMPARABLE ORGANIZATIONS (I.E., NOT-FOR-PROFIT ACADEMIC/RESEARCH MEDICAL CENTERS, ESPECIALLY THOSE SHARING A MISSION SIMILAR TO MSKCC, WITH OTHER HEALTHCARE SECTORS CONSIDERED ON A SELECTED BASIS) AND SUMMARIZES THE RELATIVE MARKET POSITION OF EACH EXECUTIVE'S TOTAL COMPENSATION. THE LAST REVIEW WAS DECEMBER 2015. THIS REVIEWS SETS THE COMPENSATION FOR THE FOLLOWING YEAR. ADDITIONALLY, A SENIOR MEMBER OF THE CONSULTING FIRM ATTENDS THE COMMITTEE'S MEETINGS TO PROVIDE INFORMATION AND TO RESPOND TO QUESTIONS BY THE MEMBERS OF THE COMMITTEE. COMPENSATION LEVELS ARE ESTABLISHED CONSIDERING THE MARKET DATA, AN ASSESSMENT OF PERFORMANCE, AND OTHER BUSINESS JUDGMENT FACTORS, CONSISTENT WITH MSKCC'S EXECUTIVE COMPENSATION PHILOSOPHY. THE COMMITTEE'S DECISIONS ARE MADE IN THE BEST INTERESTS OF MSKCC, AND ARE INTENDED TO ENSURE THE RECRUITMENT AND RETENTION OF KEY EXECUTIVE TALENT, CONSISTENT WITH THE MARKET PRACTICES OF OTHER NOT-FOR-PROFIT HEALTHCARE ORGANIZATIONS OF COMPARABLE SCOPE, MISSION AND COMPLEXITY. ON AN ANNUAL BASIS, THE COMMITTEE PROVIDES THE FULL BOARD WITH AN OVERVIEW OF ITS DETERMINATIONS AND PROCESS. THE COMMITTEE'S REVIEW PROCESS FOLLOWS THE INTERMEDIATE SANCTIONS' GUIDELINES FOR QUALIFYING FOR THE REBUTTABLE PRESUMPTION OF REASONABLENESS UNDER SECTION 4958 OF THE INTERNAL REVENUE CODE OF 1986: - THE COMPENSATION ARRANGEMENT IS APPROVED IN ADVANCE BY AN "AUTHORIZED BODY" OF THE APPLICABLE TAX EXEMPT ORGANIZATION (I.E, THE COMMITTEE, WHICH IS COMPOSED ENTIRELY OF INDIVIDUALS WHO DO NOT HAVE A CONFLICT OF INTEREST WITHIN THE MEANING OF THE REGULATIONS UNDER SECTION 4958). - THE AUTHORIZED BODY OBTAINS AND RELIES UPON "APPROPRIATE DATA AS TO COMPARABILITY" PRIOR TO MAKING ITS DETERMINATION, FOR WHICH COMPARABILITY DATA ARE PROVIDED AND ANALYZED BY SULLIVAN, COTTER AND ASSOCIATES, INC., A WELL-REGARDED EXPERT IN THE AREA OF HEALTHCARE COMPENSATION. - THE COMMITTEE ADEQUATELY DOCUMENTS THE BASIS FOR ITS DETERMINATION CONCURRENTLY WITH MAKING THAT DETERMINATION, AGAIN AS REQUIRED IN THE REGULATIONS. FORM 990, PART VI, LINE 19 THE AUDITED FINANCIAL STATEMENTS OF MEMORIAL SLOAN-KETTERING CANCER CENTER AND ITS AFFILIATES ARE AVAILABLE TO THE PUBLIC UPON REQUEST. IN ADDITION, THE FINANCIAL STATEMENTS CAN BE ACCESSED AT THE FOLLOWING WEB ADDRESS: WWW.DACBOND.COM. THE ORGANIZATION HAS ENGAGED DAC BOND AS OUR INVESTOR RELATIONS AND DISCLOSURE/DISSEMINATION AGENT. THE INFORMATION AVAILABLE ON THIS WEB SITE INCLUDES AUDITED FINANCIAL STATEMENTS, QUARTERLY UNAUDITED FINANCIAL STATEMENTS AND THE BOND OFFERING STATEMENTS FOR ALL DEBT ISSUES. IN ADDITION, COPIES OF THE GROUP 990 AND THE APPLICABLE 990T ARE ALSO AVAILABLE. THE CONFLICT OF INTEREST POLICY IS AVAILABLE TO THE PUBLIC UPON REQUEST AND IT ALSO CAN BE FOUND AT THE FOLLOWING INSTITUTIONAL WEB SITE: WWW.MSKCC.ORG. GOVERNING DOCUMENTS SUCH AS THE ARTICLES OF INCORPORATION AND CORPORATE BY-LAWS ARE NOT AVAILABLE TO THE PUBLIC. FORM 990, PART VII, SECTION B AMOUNTS PAID TO INDEPENDENT CONTRACTORS INCLUDE AMOUNTS FOR SUBCONTRACTORS AS WELL AS REIMBURSABLE EXPENSES. FORM 990, PART XI, LINE 9 CHANGE IN POSTRETIREMENT $ 7,715,000 INTEREST & COST OF ISSUANCE ON TAXABLE BONDS (39,120,092) MEMORIAL PROTON INC. WRITE DOWN (390,358) UNDER-ACCRUAL RALPH LAUREN CENTER 100,000 OTHER (2,045) NET-OTHER CHANGES IN NET ASSETS $(31,697,495) FORM 990, PART XII, LINE 2 THE FINANCIAL STATEMENTS OF MEMORIAL SLOAN-KETTERING CANCER CENTER AND ITS AFFILIATES ARE AUDITED BY AN INDEPENDENT ACCOUNTING FIRM ON A COMBINED BASIS. THE COMBINED STATEMENTS INCLUDE THE ACCOUNTS OF THE FOLLOWING TAX EXEMPT, SECTION 501 (C) (3), INCORPORATED AFFILIATES: MEMORIAL SLOAN-KETTERING CANCER CENTER (EIN 13-1924236), MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES (EIN 13-1624082), SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (EIN 13-1624182), S.K.I. REALTY, INC. (EIN 13-3389586), LOUIS V. GERSTNER JR., GRADUATE SCHOOL OF BIOMEDICAL SCIENCES (EIN 20-2212588), AND MSK INSURANCE US, INC.(MVI) EIN 83-0363317. INCLUDED IN THE GROUP EXEMPTION IS MSKCC PROPERTIES LLC (EIN 35-2464610) WITH MEMORIAL HOSPITAL BEING THE SOLE MEMBER, AND MSKCC PROTON, INC. (EIN 35-2397819). THE CENTER'S FINANCIAL STATEMENTS ARE NOT AUDITED INDEPENDENT OF THE COMBINED. REFER TO SCHEDULE D FOR A RECONCILIATION OF THE 990 TO THE CENTER'S FINANCIAL STATEMENTS. STRATEGIC PLANNING AND COMMUNITY BENEFITS THE FOLLOWING NOTES ON STRATEGIC PLANNING AND COMMUNITY BENEFITS PERTAIN TO MEMORIAL SLOAN-KETTERING CANCER CENTER AND ITS AFFILIATES AS REPORTED ON A COMBINED BASIS WITH A SEPARATE GROUP 990 FILING UNDER EIN # 91-2154236. MEMORIAL SLOAN-KETTERING CANCER CENTER AND ITS AFFILIATES ARE INTERTWINED WITH COMMUNITY BENEFITS AND FINANCIAL ASSISTANCE ACTIVITIES AS OUTLINED BELOW. MSKCCS STRATEGIC PLANNING PROCESS INCLUDES DEVELOPING SERVICES AND PROGRAMS IN RESPONSE TO CANCER MORBIDITY AND MORTALITY DATA, DEMOGRAPHIC DATA, AND COMMUNITY INPUT IN ACCORDANCE WITH ITS IRS "COMMUNITY HEALTH NEEDS ASSESSMENTS" REQUIREMENTS. THESE FINDINGS AND RESULTS ARE USED IN DESIGNING AN IMPLEMENTATION STRATEGY TO PLAN INITIATIVES AND PROGRAMS AIMED AT IMPROVING OUR COMMUNITYS ACCESS TO CANCER INFORMATION. IN ADDITION, THE ORGANIZATIONS STRATEGIC EFFORTS ARE FOCUSED ON REDUCING THE CRITICAL ISSUE OF CANCER HEALTH DISPARITIES AMONG MINORITY AND MEDICALLY UNDERSERVED POPULATIONS. MSKCCS INPATIENT HOSPITAL IS LOCATED IN MID-MANHATTAN WITH ADDITIONAL OUTPATIENT TREATMENT CENTERS IN BROOKLYN, LONG ISLAND, WESTCHESTER COUNTY, AND NEW JERSEY. OUR PRIMARY CATCHMENT AREA ENCOMPASSES 23 COUNTIES ACROSS THE SAME LOCATIONS AS OUR FACILITIES. A TOTAL OF 162,151 PATIENTS WERE SEEN AT MSKCCS FACILITIES IN 2016, INCLUDING 146,668 PATIENTS FROM THE TRI-STATE AREA (NY, NJ, CT); 13,508 PATIENTS FROM OTHER PARTS OF THE UNITED STATES; AND 1,975 PATIENTS FROM OTHER COUNTRIES. THESE PATIENTS ACCOUNTED FOR 23,078 ADMISSIONS TO THE HOSPITAL AND 665,593 OUTPATIENT VISITS AT THE COMBINED FACILITIES IN NEW YORK CITY AND THE REGION. SINCE 1987, MSKCC HAS HAD A FINANCIAL ASSISTANCE PROGRAM (FAP) IN PLACE TO ASSIST UNDERINSURED AND UNINSURED PATIENTS WHO ARE EXPERIENCING DIFFICULTIES MEETING THEIR FINANCIAL RESPONSIBILITIES TO MEMORIAL HOSPITAL AND ITS PHYSICIANS. FINANCIAL COUNSELORS ARE AVAILABLE TO WORK WITH PATIENTS AND INSURANCE COMPANIES INCLUDING MEDICARE AND MEDICAID TO HELP THE PATIENTS GAIN ACCESS TO SERVICES. FOR THOSE WHO DONT QUALIFY FOR PUBLICLY AVAILABLE HEALTH INSURANCE OR WHO ARE UNABLE TO PAY THEIR PORTION OF FEES ABOVE INSURANCE REIMBURSEMENT, MSKCC MAY PROVIDE FINANCIAL HELP TO THOSE WHO ARE ELIGIBLE THROUGH ITS FINANCIAL ASSISTANCE PROGRAM. DURING THE REGISTRATION PROCESS, FINANCIAL INTERVIEWERS EDUCATE PATIENTS ON THE VARIOUS PROGRAMS AVAILABLE TO THEM. MSKCC SENDS A COPY OF THE FAP BROCHURE WITH THE INITIAL HOSPITAL BILL TO EVERY NEW PATIENT TO MAKE THEM AWARE OF THE CHARITY CARE/FINANCIAL ASSISTANCE PROGRAM. THE FAP IS ALSO MENTIONED ON EVERY PATIENT STATEMENT AND LETTER THAT IS SENT TO A PATIENT AND ON EVERY COLLECTION LETTER SENT TO PATIENTS BY THE COLLECTION AGENCIES. EVEN AFTER A PATIENT ACCOUNT IS SENT TO COLLECTIONS THEY CAN STILL APPLY FOR FINANCIAL ASSISTANCE. IT IS NEVER TOO LATE TO APPLY FOR FINANCIAL ASSISTANCE AND RETRO ACTIVE FAP COVERAGE WOULD BE GIVEN IF A PATIENT IS DETERMINED ELIGIBLE. INFORMATION ABOUT THE FAP IS ALSO AVAILABLE ON THE WEBSITE AT WWW.MSKCC.ORG/FINANCIAL-ASSISTANCE. A PATIENT WITH INCOME LESS THAN OR EQUAL TO 500% OF THE FEDERAL POVERTY GUIDELINES (FPG) IS ELIGIBLE FOR THE FAP. MSKCC MAY REDUCE THE FEES INCURRED BY THE PATIENT OR ACCEPT AS FULL PAYMENT AMOUNTS PAID BY THE INSURANCE CARRIER ON THE PATIENTS BEHALF. A PATIENT MAY ALSO QUALIFY FOR ASSISTANCE EVEN IF HIS/HER INCOME IS GREATER THAN THE THRESHOLD LIMIT. MSKCC ADJUSTS THE PATIENTS INCOME FOR ROUTINE MONTHLY EXPENSES, INCLUDING TAXES, TO DETERMINE DISPOSABLE INCOME. MSKCC ALSO DEDUCTS A SPECIFIC AMOUNT (DEBT BURDEN) AS MONTHLY CLOTHES AND FOOD ALLOWANCE BASED ON A PATIENTS FAMILY SIZE IN EVALUATING THE TYPE AND AMOUNT OF ASSISTANCE NEEDED. THE TABLE BELOW ILLUSTRATES THE INCOME GUIDELINES USED IN EVALUATING A PATIENTS FINANCIAL STATUS. 2016 INCOME GUIDELINES: FAMILY ALLOWED RESOURCE SIZE INCOME LEVELS 1 $ 59,400 $33,096 2 $80,100 $40,734 3 $100,800 $48,372 4 $121,500 $56,012 5 $142,200 $63,856 6 $162,900 $71,288 MSKCC ENGAGES IN AND SUPPORTS COALITION BUILDING ACTIVITIES THAT PROMOTE THE HEALTH OF THE COMMUNITIES THE INSTITUTION SERVES. STAFF MEMBERS ARE ENCOURAGED TO SHARE THEIR CLINICAL EXPERTISE AND EXPERIENCE WITH PARTNERING HEALTHCARE FACILITIES AND COMMUNITY ORGANIZATIONS. THEY SERVE AND PARTICIPATE IN NUMEROUS COMMUNITY GROUPS INCLUDING THE AMERICAN CANCER SOCIETY, THE AMERICAN PUBLIC HEALTH ASSOCIATION, THE GREATER NEW YORK HOSPITAL ASSOCIATION, AND MANY HEALTH IMPROVEMENT ADVOCACY GROUPS FOR PARTICULAR TYPES OF CANCER. ALTHOUGH THE SIGNIFICANT COST OF STAFF TIME DEVOTED TO THESE ACTIVITIES IS NOT QUANTIFIED BY THE CENTER, THE INSTITUTION CONSIDERS THESE EFFORTS TO COLLABORATE AND BUILD COMMUNITY RESOURCES TO BE OF SIZEABLE COMMUNITY BENEFIT. MSKCC CONDUCTED A COMMUNITY HEALTH NEEDS ASSESSMENT (CHNA) IN THE FALL OF 2016 TO DETERMINE THE CRITICAL CANCER-RELATED HEALTH CONCERNS FACING RESIDENTS IN OUR 23-COUNTY CATCHMENT AREA. WE ANALYZED CANCER STATISTICS ON INCIDENCE, PREVALENCE, AND MORTALITY AND REVIEWED KEY HEALTH TRENDS AMONG CANCER PATIENTS, MULTICULTURAL POPULATIONS AND THE GENERAL PUBLIC. TO ENGAGE THE BROAD COMMUNITY IN OUR HEALTH NEEDS ASSESSMENT, MSKCC HELD A SERIES OF COMMUNITY FORUMS IN HARLEM, BROOKLYN, AND MANHATTAN, TO CONNECT WITH REPRESENTATIVES FROM COMMUNITY-BASED ORGANIZATIONS THAT SERVE CLIENTS THROUGHOUT NEW YORK CITY AND ITS SURROUNDING COMMUNITIES. REPRESENTATIVES FROM 22 COMMUNITY BASED ORGANIZATIONS PARTICIPATED IN THE FORUMS AND SERVE A DIVERSE RANGE OF CLIENTS. SERVICES PROVIDED BY THESE ORGANIZATIONS INCLUDE CANCER SUPPORT SERVICES, DOMESTIC VIOLENCE SUPPORT, IMMIGRATION ASSISTANCE, AND PRIMARY CARE SERVICES. SUMMARY FINDINGS OF MSKCC S CHNA WERE SENT TO COMMUNITY BASED ORGANIZATIONS WITH WHOM WE WORK AND WERE ALSO INCORPORATED INTO OUR ANNUAL COMMUNITY SERVICE PLAN REPORT (CSP). THE CSP IS DISTRIBUTED TO LOCAL ELECTED OFFICIALS, ORGANIZATIONS, AND IS AVAILABLE TO THE PUBLIC AT WWW.MSKCC.ORG/COMMUNITYSERVICEPLANS. THE CHNA WAS ALSO PUBLICIZED THROUGH OUR COMMUNITY NEWSLETTERS WHICH ARE DISTRIBUTED TO APPROXIMATELY 50,000 RESIDENTS NEAR OUR TREATMENT FACILITIES. EDUCATION AND TRAINING ARE KEY COMPONENTS OF MSKCC'S MISSION, AND IMPORTANT EXAMPLES OF HOW THE INSTITUTION MAKES CONTRIBUTIONS TO THE CARE AND TREATMENT OF CANCER PATIENTS FAR BEYOND ITS OWN WALLS THROUGH WORKFORCE DEVELOPMENT. OUR TRAINING, GRADUATE, AND CONTINUING EDUCATION PROGRAMS PREPARE PHYSICIANS, SCIENTISTS, NURSES, AND TECHNICIANS TO BE LEADERS IN THEIR CHOSEN FIELDS. THESE HEALTHCARE PROVIDERS CAN THEN TAKE THE EXPERTISE GAINED FROM WORKING WITH OUR SPECIALISTS TO OTHER HEALTHCARE INSTITUTIONS AROUND THE COUNTRY AND THROUGHOUT THE WORLD. MSKCC ALSO TRAINS GRADUATE STUDENTS AND POSTDOCTORAL RESEARCHERS WORKING IN MANY AREAS OF BASIC SCIENCE AND TRANSLATIONAL RESEARCH. WHEN THESE YOUNG SCIENTISTS COMPLETE THEIR TRAINING, THEY BRING THE SKILLS OBTAINED IN OUR LABORATORIES INTO THE ACADEMIC COMMUNITY AT LARGE AS WELL AS THE PRIVATE SECTOR. MSKCC SPONSORS SEVERAL PROGRAMS THAT GIVE MEDICAL STUDENTS, UNDERGRADUATES, AND HIGH SCHOOL STUDENTS THE OPPORTUNITY TO WORK AT THE INSTITUTION DOING CLINICAL AND LABORATORY RESEARCH. THROUGH THESE PROGRAMS MSKCC STRIVES TO INCREASE THE PIPELINE OF SCIENTISTS AND PHYSICIANS WORKING IN ONCOLOGY. MSKCCS OFFICE OF DIVERSITY PROGRAMS IN CLINICAL CARE, RESEARCH, AND TRAINING (ODP) PROVIDES FUNDING TO ENCOURAGE INTEREST IN PURSUING CAREERS IN THE FIELD OF ONCOLOGY FOR MEMBERS OF MINORITY GROUPS WHO ARE UNDERREPRESENTED IN MEDICINE AND WISH TO PARTICIPATE IN THE NATIONAL CANCER INSTITUTES MEDICAL STUDENTS SUMMER FELLOWSHIP PROGRAM. THE ODP ALSO COORDINATES A SIX-WEEK SUMMER EXPOSURE PROGRAM TO EXPOSE UNDERREPRESENTED MINORITY HIGH SCHOOL STUDENTS TO CAREERS IN MEDICINE AND RESEARCH. MEMORIAL SLOAN KETTERING CANCER CENTER UTILIZED $188M OF THE INSTITUTIONS RESOURCES DURING 2016 TO SUPPORT ITS EDUCATION AND TRAINING MISSION, WHICH WE SEE AS VITAL GIVEN OUR LEADERSHIP ROLE IN CANCER CARE TREATMENT AND RESEARCH. MSKCC FOCUSES ON MULTIDISCIPLINARY CARE, WHERE EXPERTS FROM MANY FIELDS OF MEDICINE COME TOGETHER TO DEVELOP THE BEST TREATMENTS FOR INDIVIDUAL PATIENTS AS WELL AS FOR PATIENTS AS A WHOLE WITH ANY PARTICULAR TYPE OF CANCER. THIS HAS ALLOWED US TO BE AT THE FOREFRONT OF DEVELOPING TREATMENTS THAT ARE MORE EFFECTIVE AT TREATING CANCER WHILE AT THE SAME TIME SPARING MANY PATIENTS FROM THE MOST SERIOUS SIDE EFFECTS OF TREATMENT. OUR BASIC AND TRANSLATIONAL RESEARCHERS HAVE MADE MANY SIGNIFICANT CONTRIBUTIONS TO THE SCIENTIFIC COMMUNITYS UNDERSTANDING OF CANCER BIOLOGY AND CANCER GENETICS AS WELL AS TO RELATED FIELDS -- CELL BIOLOGY, MOLECULAR BIOLOGY, STRUCTURAL BIOLOGY, DEVELOPMENTAL BIOLOGY, MOLECULAR PHARMACOLOGY AND CHEMISTRY, IMMUNOLOGY, COMPUTATIONAL BIOLOGY, AND DRUG DEVELOPMENT. GENES FIRST IDENTIFIED IN OUR LABORATORIES ARE NOW THE FOCUS OF INTENSE RESEARCH IN OTHER LABORATORIES AROUND THE WORLD. DRUGS, MONOCLONAL ANTIBODIES, AND OTHER AGENTS FIRST DEVELOPED IN OUR LABORATORIES HAVE GONE ON TO GAIN REGULATORY APPROVAL FOR TREATING PATIENTS WORLDWIDE. RECENT EXPANSION OF OUR LABORATORY SPACE HAS ALLOWED US TO GROW OUR RESEARCH EFFORTS SO THAT GOING FORWARD WE CAN CONTINUE TO MAKE DISCOVERIES THAT WILL CHANGE THE WAY THE WORLD UNDERSTANDS CANCER AND AID IN THE DEVELOPMENT OF BETTER TREATMENTS FOR CANCER PATIENTS EVERYWHERE. IN 2016, MEMORIAL SLOAN KETTERING CANCER CENTER EXPENDED $635.2M IN SUPPORT OF ITS RESEARCH MISSION. SUPPORT OF ITS RESEARCH MISSION. PROSTATE CANCER CLINICAL TRIALS 1275 YORK AVE NEW YORK NY 10065 352506225 CANCER CARE DE 4152000 1364000 MSKCC RALPH LAUREN CTR FOR CANCER & PRVENTION 1919 MADISON AVENUE NEW YORK NY 10036 020597827 CANCER CARE NY 501( c)3 10 MSKCC true MEMORIAL MEDICAL CARE PC 1275 YORK AVENUE NEW YORK NY 10065 352491455 CANCER CARE NY 501 (C )3 10 MSKCC true BYRNE FD FBO MSKCC 3 LARMIE ROAD-BOX 599 ETNA NH 03750 020462932 SUPPORTING DE 501 (C) 3 12D III-O NA false MEM CRITICAL CARE 1275 YORK AVE NY NY 10065 133348785 HEALTH CARE NY MEM related 0 0 false 0 true 0.01000 MEM RADIATION ONCOL 1275 YORK AVE NY NY 10065 133237927 HEALTH CARE NY MEM RELATED 0 0 false 0 true 0.01000 MEM PATHOLOGY GROUP 1275 YORK AVE NY NY 10065 133365998 HEALTH CARE NY MEM RELATED 0 0 false 0 true 0.01000 MEM ANESTHESIOLOGY 1275 YORK AVE NY NY 10065 133367135 HEALTH CARE NY MEM RELATED 0 0 false 0 true 0.01000 MEM PEDIATRICS GRP 1275 YORK AVE NY NY 10065 133346908 HEALTH CARE NY MEM RELATED 0 0 false 0 true 0.01000 MEM NEUROLOGY GROUP 1275 YORK AVE NY NY 10065 133399377 HEALTH CARE NY MEM RELATED 0 0 false 0 true 0.01000 MEM PSYCHIATRY GRP 1275 YORK AVE NY NY 10065 133430629 HEALTH CARE NY MEM RELATED 0 0 false 0 true 0.01000 MSKCC GUTTMAN 1275 YORK AVE NY NY 10065 133875002 HEALTH CARE NY MEM RELATED 0 0 false 0 true 0.01000 MSKCC PHYS PHELPS 1275 YORK AVE NY NY 10065 133897156 HEALTH CARE NY MEM RELATED 0 0 false 0 true 0.01000 MSK AT MERCY 1275 YORK AVE NY NY 10065 133954858 HEALTH CARE NY MEM RELATED 0 0 false 0 true 0.01000 MSK PHY ST CLARE'S 1275 YORK AVE NY NY 10065 133897154 HEALTH CARE NY MEM RELATED 0 0 false 0 true 0.01000 MEM INFECT DISEASE 1275 YORK AVE NY NY 10065 133278582 HEALTH CARE NY MEM RELATED 0 0 false 0 true 0.01000 MSK REHABILITATION 1275 YORK AVE NY NY 10065 134010371 HEALTH CARE NY MEM RELATED 0 0 false 0 true 0.01000 MSK SURGERY GROUP 1275 YORK AVE NY NY 10065 134010372 HEALTH CARE NY MEM RELATED 0 0 false 0 true 0.01000 MSK HAUPPAUGE 1275 YORK AVE NY NY 10065 134059247 HEALTH CARE NY MEM RELATED 0 0 false 0 true 0.01000 MEM NEUROSURGERY 1275 YORK AVE NY NY 10065 133251621 HEALTH CARE NY MEM RELATED 0 0 false 0 true 0.01000 INTERGRATIVE MED 1275 YORK AVE NY NY 10065 542092060 HEALTH CARE NY MEM RELATED 0 0 false 0 true 0.01000 MSK-REGIONAL NETWK 1275 YORK AVE NY NY 10065 020594889 HEALTH CARE NY MEM RELATED 0 0 false 0 true 0.01000 MSK BASKING RIDGE 1275 YORK AVE NY NY 10065 593801080 HEALTH CARE NY MEM RELATED 0 0 false 0 true 0.01000 MEM URGENT CARE GRP 1275 YORK AVE NY NY 10065 651263291 HEALTH CARE NY MEM RELATED 0 0 false 0 true 0.01000 MEM CLN GENETICS 1275 YORK AVE NY NY 10065 651263292 HEALTH CARE NY MEM RELATED 0 0 false 0 true 0.01000 MEM DEVELOP CHEMO 1275 YORK AVE NY NY 10065 133278548 HEALTH CARE NY MEM RELATED 0 0 false 0 true 0.01000 MEM MEDICAL CONSULT 1275 YORK AVE NY NY 10065 133278550 HEALTH CARE NY MEM RELATED 0 0 false 0 true 0.01000 MSK CLINIC PRACTICE 1275 YORK AVE NY NY 10065 510616510 HEALTH CARE NY MEM RELATED 0 0 false 0 true 0.01000 MEM BREAST GROUP 1275 YORK AVE NY NY 10065 562568640 HEALTH CARE NY MEM RELATED 0 0 false 0 true 0.01000 MEM COLORECTAL GRP 1275 YORK AVE NY NY 10065 562568642 HEALTH CARE NY MEM RELATED 0 0 false 0 true 0.01000 MEM DENTAL GRP 1275 YORK AVE NY NY 10065 562568630 HEALTH CARE NY MEM RELATED 0 0 false 0 true 0.01000 MEM CLINICAL IMMUNO 1275 YORK AVE NY NY 10065 133278559 HEALTH CARE NY MEM RELATED 0 0 false 0 true 0.01000 MEM GASTRIC MIX TMR 1275 YORK AVE NY NY 10065 562568650 HEALTH CARE NY MEM RELATED 0 0 false 0 true 0.01000 MEM GYNECOLOGY GRP 1275 YORK AVE NY NY 10065 562568655 HEALTH CARE NY MEM RELATED 0 0 false 0 true 0.01000 MEM HEAD & NECK GRP 1275 YORK AVE NY NY 10065 562568656 HEALTH CARE NY MEM RELATED 0 0 false 0 true 0.01000 MEM HEPATOBILIARY 1275 YORK AVE NY NY 10065 562568667 HEALTH CARE NY MEM RELATED 0 0 false 0 true 0.01000 MEM NEUROSURGERY GP 1275 YORK AVE NY NY 10065 562568663 HEALTH CARE NY MEM RELATED 0 0 false 0 true 0.01000 MEM NUTRITION GRP 1275 YORK AVE NY NY 10065 133278576 HEALTH CARE NY MEM RELATED 0 0 false 0 true 0.01000 MEM OPT ABRAMSON GP 1275 YORK AVE NY NY 10065 562568627 HEALTH CARE NY MEM RELATED 0 0 false 0 true 0.01000 MEM OPTHALMIC ONOCO 1275 YORK AVE NY NY 10065 562568675 HEALTH CARE NY MEM RELATED 0 0 false 0 true 0.01000 OPTHALMOLOGY GP 1275 YORK AVE NY NY 10065 562568669 HEALTH CARE NY MEM RELATED 0 0 false 0 true 0.01000 MEM ORTHOPEDIC GRP 1275 YORK AVE NY NY 10065 562568680 HEALTH CARE NY MEM RELATED 0 0 false 0 true 0.01000 MEM PEDIATRIC SURG 1275 YORK AVE NY NY 10065 562568683 HEALTH CARE NY MEM RELATED 0 0 false 0 true 0.01000 MEM CLINICAL PHY 1275 YORK AVE NY NY 10065 133278556 HEALTH CARE NY MEM RELATED 0 0 false 0 true 0.01000 MEM PLASTIC RECON 1275 YORK AVE NY NY 10065 562568623 HEALTH CARE NY MEM RELATED 0 0 false 0 true 0.01000 MEM THORACIC GRP 1275 YORK AVE NY NY 10065 562568677 HEALTH CARE NY MEM RELATED 0 0 false 0 true 0.01000 MEM UROLOGY GRP 1275 YORK AVE NY NY 10065 562568638 HEALTH CARE NY MEM RELATED 0 0 false 0 true 0.01000 MEM PAIN SERVICE 1275 YORK AVE NY NY 10065 651283822 HEALTH CARE NY MEM RELATED 0 0 false 0 true 0.01000 MEM SOLID TUMOR GRP 1275 YORK AVE NY NY 10065 133278578 HEALTH CARE NY MEM related 0 0 false 0 true 0.01000 MEM DERMATOLOGY GRP 1275 YORK AVE NY NY 10065 133278581 HEALTH CARE NY MEM related 0 0 false 0 true 0.01000 MEM ENDOCRINE GRP 1275 YORK AVE NY NY 10065 133278583 HEALTH CARE NY MEM RELATED 0 0 false 0 true 0.01000 GASTROENTEROLOGY 1275 YORK AVE NY NY 10065 133278574 HEALTH CARE NY MEM RELATED 0 0 false 0 true 0.01000 MEM HEMATOLOGYLYMP 1275 YORK AVE NY NY 10065 133278575 HEALTH CARE NY MEM RELATED 0 0 false 0 true 0.01000 MEM PULMONARY FUNC 1275 YORK AVE NY NY 10065 133304834 HEALTH CARE NY MEM RELATED 0 0 false 0 true 0.01000 MEM CARDIOPULMONARY 1275 YORK AVE NY NY 10065 133278552 HEALTH CARE NY MEM RELATED 0 0 false 0 true 0.01000 MSKCC RADIOLOGY GRP 1275 YORK AVE NY NY 10065 133375559 HEALTH CARE NY MEM RELATED 0 0 false 0 true 0.01000 MEM NUCLEAR MED 1275 YORK AVE NY NY 10065 133278580 HEALTH CARE NY MEM RELATED 0 0 false 0 true 0.01000 CHARITABLE REMAINDER TRUSTS 178 false true false false false false false false false true true true false false false true false false MEMORIAL HOSPITAL FOR CANCER & ALLIED DISEASE L 403630000 COST SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH L 91965000 COST SKI REALTY INC L 1600000 COST LOUIS V GERSTNER JR GRADUATE SCHOOL L 101000 COST MEMORIAL HOSPITAL FOR CANCER & ALLIED DISEASE M 8731000 COST SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH M 7487000 COST SKI REALTY INC K 2319000 cost RALPH LAUREN CTR FOR CANCER & PREVENTION Q 2573000 COST RALPH LAUREN CTR FOR CANCER & PREVENTION B 1100000 cost